Progress in the development of RBC substitutes (Q34175158)

31 July 2017

1 reference

title

Progress in the development of RBC substitutes (English)

1 reference

31 July 2017

Stowell CP

1

1 reference

31 July 2017

Levin J

series ordinal

2

1 reference

31 July 2017

Spiess BD

series ordinal

3

1 reference

31 July 2017

Winslow RM

series ordinal

4

1 reference

31 July 2017

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

41

1 reference

31 July 2017

287-299

1 reference

31 July 2017

2

1 reference

Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Survival of Mammals Breathing Organic Liquids Equilibrated with Oxygen at Atmospheric Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Complement activation by artificial blood substitute Fluosol: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Influence of perflubron emulsion particle size on blood half-life and febrile response in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Specific identification of hemoglobin and myoglobin in renal tubular casts by the fluorescent antibody technic on fixed embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Perfluorocarbon emulsion in the cardiopulmonary bypass prime reduces neurologic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

New variant Creutzfeldt-Jakob disease (nvCJD): the risk of transmission by blood transfusion and the potential benefit of leukocyte-reduction of blood components

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Microvascular and tissue oxygen distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Immunological effects of hemoglobin, encapsulated hemoglobin, polyhemoglobin and conjugated hemoglobin using different immunization schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

A human recombinant haemoglobin designed for use as a blood substitute

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Acute changes in systemic blood pressure and urine output of conscious rats following exchange transfusion with diaspirin-crosslinked hemoglobin solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Haemoglobin-based blood substitutes and sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Safety evaluation of a polymerized hemoglobin solution in a murine infection model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Transfusion medicine. First of two parts--blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

The development of recombinant human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Increased tumor oxygenation and radiation sensitivity in two rat tumors by a hemoglobin-based, oxygen-carrying preparation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

The cost effectiveness of preoperative autologous blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Perceptions and preferences of autologous blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41020287.X

10.1046/J.1537-2995.2001.41020287.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference